Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The profile of chronic liver disease has changed due to obesity trends and advances in the treatment of hepatitis C.
The 2019 Liver Meeting in Boston provided an array of important findings about the treatment and prevention of chronic liver diseases.
A pair of studies found that bacteriophage therapy may treat alcoholic hepatitis and primary sclerosing cholangitis.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.